Rheumatoid arthritis is associated with left ventricular concentric remodeling: Results of a population-based cross-sectional study

Arthritis and Rheumatism

Volumn 65, Issue 7, 2013, Pages 1713-1718

  Myasoedova, Elena ^a   Davis III, John M ^a   Crowson, Cynthia S ^a   Roger, Véronique L ^a   Karon, Barry L ^a   Borgeson, Daniel D ^a   Therneau, Terry M ^a   Matteson, Eric L ^a   Rodeheffer, Richard J ^a   Gabriel, Sherine E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEART DISEASE; HEART FAILURE; HEART LEFT VENTRICLE CONCENTRIC REMODELING; HUMAN; HYPERTROPHY; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; THICKNESS; CASE CONTROL STUDY; ECHOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; MIDDLE AGED; PHYSIOLOGY; RISK; STATISTICAL MODEL;

ADRENAL CORTEX HORMONES; AGED; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LINEAR MODELS; MALE; MIDDLE AGED; ODDS RATIO; VENTRICULAR REMODELING;

EID: 84879872797     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.37949     Document Type: Article

References (17)

1. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005; 52: 412-20.
2. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.
3. Masiha S, Sundstrom J, Lind L,. Inflammatory markers are associated with left ventricular hypertrophy and diastolic dysfunction in a population-based sample of elderly men and women. J Hum Hypertens 2013; 27: 13-7.
4. Kremers HM, Myasoedova E, Crowson CS, Savova G, Gabriel SE, Matteson EL,. The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases. Rheumatology (Oxford) 2011; 50: 6-15.
5. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
6. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ,. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289: 194-202.
7. Liang KP, Myasoedova E, Crowson CS, Davis JM, Roger VL, Karon BL, et al. Increased prevalence of diastolic dysfunction in rheumatoid arthritis. Ann Rheum Dis 2010; 69: 1665-70.
8. Fries JF, Spitz P, Kraines RG, Holman HR,. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-45.
9. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al, for the Chronic Kidney Disease Epidemiology Collaboration. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007; 53: 766-72.
10. Smets P, Meyer E, Maddens B, Daminet S,. Cushing's syndrome, glucocorticoids and the kidney. Gen Comp Endocrinol 2010; 169: 1-10.
11. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, et al. The relationship of left ventricular mass and geometry to incident cardiovascular events: the MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 2008; 52: 2148-55.
12. Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahlof B, Devereux RB,. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr 2008; 9: 809-15.
13. Corrao S, Salli L, Arnone S, Scaglione R, Pinto A, Licata G,. Echo-Doppler left ventricular filling abnormalities in patients with rheumatoid arthritis without clinically evident cardiovascular disease. Eur J Clin Invest 1996; 26: 293-7.
14. Giles JT, Malayeri AA, Fernandes V, Post W, Blumenthal RS, Bluemke D, et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthritis Rheum 2010; 62: 940-51.
15. Rudominer RL, Roman MJ, Devereux RB, Paget SA, Schwartz JE, Lockshin MD, et al. Independent association of rheumatoid arthritis with increased left ventricular mass but not with reduced ejection fraction. Arthritis Rheum 2009; 60: 22-9.
16. Hafezi-Moghadam A, Simoncini T, Yang Z, Limbourg FP, Plumier JC, Rebsamen MC, et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 2002; 8: 473-9.
17. Crowson CS, Myasoedova E, Davis JM III, Matteson EL, Roger VL, Therneau TM, et al. Increased prevalence of metabolic syndrome associated with rheumatoid arthritis in patients without clinical cardiovascular disease. J Rheumatol 2011; 38: 29-35. Skin Diseases